382 related articles for article (PubMed ID: 26254405)
1. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
3. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K
World J Gastroenterol; 2015 Sep; 21(34):9966-73. PubMed ID: 26379401
[TBL] [Abstract][Full Text] [Related]
5. The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Iseki Y; Ikeya T; Sugano K; Hirakawa K
BMC Cancer; 2015 May; 15():347. PubMed ID: 25934494
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M
BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
8. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
9. The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Hirakawa K; Ohira M
Springerplus; 2016; 5(1):1798. PubMed ID: 27812440
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors.
Maeda K; Shibutani M; Otani H; Nagahara H; Sugano K; Ikeya T; Amano R; Kimura K; Sakurai K; Kubo N; Muguruma K; Tanaka H; Inoue T; Hirakawa K
Anticancer Res; 2013 Dec; 33(12):5567-73. PubMed ID: 24324099
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
Seong MK
J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
[TBL] [Abstract][Full Text] [Related]
13. New Prognostic Indicator is Useful for Predicting the Survival of Patients with Unresectable Advanced Colorectal Cancer.
Ikeguchi M; Ashida K; Saito H
Hepatogastroenterology; 2015 Jun; 62(140):859-62. PubMed ID: 26902016
[TBL] [Abstract][Full Text] [Related]
14. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Iseki Y; Ikeya T; Sugano K; Hirakawa K
World J Surg Oncol; 2015 Jun; 13():194. PubMed ID: 26040932
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pre-operative inflammatory markers in resected gallbladder cancer: a systematic review.
Saqib R; Pathak S; Smart N; Nunes Q; Rees J; Finch Jones M; Poston G
ANZ J Surg; 2018 Jun; 88(6):554-559. PubMed ID: 29205753
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy.
Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Wang EN; Maeda K; Hirakawa K; Ohira M
Anticancer Res; 2019 Feb; 39(2):1051-1057. PubMed ID: 30711994
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K
Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
20. Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted Therapy.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Clin Genitourin Cancer; 2017 Aug; 15(4):495-501. PubMed ID: 28363437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
